Medusa Pharmaceuticals

Medusa Pharmaceuticals is a pioneering biotechnology research company dedicated to developing innovative solutions to combat antimicrobial resistance (AMR). As an Imperial College London spin-out, Medusa Pharmaceuticals focuses on novel synergistic combinations of repurposed drugs, aiming to overcome the growing challenges posed by AMR. The company is committed to advancing healthcare through cutting-edge research and development.

Located at Campus, Babraham Research, Cambridge, CB22 3AT, GB, Medusa Pharmaceuticals operates at the forefront of biotechnology, striving to create impactful therapies that address critical needs in the medical field. With a focus on synergy and repurposing, the company leverages scientific expertise to deliver effective and sustainable solutions.

Medusa Pharmaceuticals is poised for significant growth and is dedicated to making a substantial contribution to the healthcare industry. The company's commitment to innovation and excellence drives its mission to develop groundbreaking treatments for antimicrobial resistance. We invite the management team at Medusa Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and potential.